These rearrangements, resulting from chromosomal translocations involving the KMT2A (MLL) gene at 11q23, occur in approximately 5–10% of all AML cases and are most commonly observed in pediatric patients [4]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.